In turn, the E2 component of PDC (PDC-E2) is the key autoantigen in primary biliary cholangitis (PBC), a chronic cholestatic liver disease with autoimmune phenome targeting intrahepatic bile duct lining cells, i.e., cholangiocytes4. Here, DLAT is linked to primary biliary cholangitis.